493 related articles for article (PubMed ID: 30880094)
1. The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care.
Alawadi F; Rashid F; Bashier A; Abdelgadir E; Al Saeed M; Abuelkheir S; Khalifa A; Al Sayyah F; Bachet F; Elsayed M; Abdallah K; Hassanein M
Diabetes Res Clin Pract; 2019 May; 151():305-312. PubMed ID: 30880094
[TBL] [Abstract][Full Text] [Related]
2. Assessment of risk of fasting during Ramadan under optimal diabetes care, in high-risk patients with diabetes and coronary heart disease through the use of FreeStyle Libre flash continuous glucose monitor (FSL-CGMS).
Hassanein M; Rashid F; Elsayed M; Basheir A; Al Saeed M; Abdelgadir E; AbuelKheir S; Khalifa A; Al Sayyah F; Bachet F; Jacob S; Alawadi F
Diabetes Res Clin Pract; 2019 Apr; 150():308-314. PubMed ID: 30771364
[TBL] [Abstract][Full Text] [Related]
3. The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes.
Hassanein M; Abdelgadir E; Bashier A; Rashid F; Saeed MA; Khalifa A; Eltayb F; Abuelkheir S; Abdellatif M; Sayyah F; Khalifa S; Alawadi F
Diabetes Res Clin Pract; 2019 Apr; 150():288-295. PubMed ID: 30641167
[TBL] [Abstract][Full Text] [Related]
4. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.
Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M
Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155
[TBL] [Abstract][Full Text] [Related]
5. The value of Continuous Glucose Monitoring and Self-Monitoring of Blood Glucose in patients with Gestational Diabetes Mellitus during Ramadan fasting.
Afandi B; Hassanein M; Roubi S; Nagelkerke N
Diabetes Res Clin Pract; 2019 May; 151():260-264. PubMed ID: 30822494
[TBL] [Abstract][Full Text] [Related]
6. Impact of optimum diabetes care on the safety of fasting in Ramadan in adult patients with type 2 diabetes mellitus on insulin therapy.
Bashier AMK; Hussain AKB; Alawadi F; Alsayyah F; Alsaeed M; Rashid F; Abdelgadir E; Bachet F; Abuelkheir S; Elsayed M; Hassanein M
Diabetes Res Clin Pract; 2019 Apr; 150():301-307. PubMed ID: 30768940
[TBL] [Abstract][Full Text] [Related]
7. Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes.
Abdelgadir E; Rashid F; Bashier A; Al Saeed M; Khalifa A; Alawadi F; Hassanein M
Diabetes Metab Syndr; 2019; 13(5):2927-2932. PubMed ID: 31425958
[TBL] [Abstract][Full Text] [Related]
8. Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study).
Elhadd T; Bashir M; Baager KA; Ali HA; Almohannadi DHS; Dabbous Z; Malik RA; Abou-Samra AB;
Diabetes Res Clin Pract; 2021 Feb; 172():108589. PubMed ID: 33316309
[TBL] [Abstract][Full Text] [Related]
9. Comparison of continuous glucose monitoring in adolescents with type 1 diabetes: Ramadan versus non-Ramadan.
Kaplan W; Afandi B; Al Hassani N; Hadi S; Zoubeidi T
Diabetes Res Clin Pract; 2017 Dec; 134():178-182. PubMed ID: 29061323
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of optimum diabetes care on glycemic control of patients with gestational diabetes during Ramadan fasting.
Hassanein M; Abuelkheir S; Alsayyah F; Twair M; Abdelgadir E; Basheir A; Rashid F; Al Saeed M; Eltayb F; Abdellatif M; Khalifa A; Alawadi F
Diabetes Res Clin Pract; 2021 Mar; 173():108669. PubMed ID: 33460717
[TBL] [Abstract][Full Text] [Related]
11. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes.
Afandi B; Kaplan W; Al Hassani N; Hadi S; Mohamed A
J Endocrinol Invest; 2017 Jul; 40(7):741-744. PubMed ID: 28239763
[TBL] [Abstract][Full Text] [Related]
12. Fasting outcomes in people with diabetes and chronic kidney disease in East London during Ramadan 2018: The East London diabetes in Ramadan survey.
Chowdhury A; Khan H; Lasker SS; Chowdhury TA
Diabetes Res Clin Pract; 2019 Jun; 152():166-170. PubMed ID: 31150726
[TBL] [Abstract][Full Text] [Related]
13. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
[TBL] [Abstract][Full Text] [Related]
14. A pilot study using flash continuous glucose monitoring in patients with type-2 diabetes on multiple anti-diabetic agents during Ramadan.
Bashir M; Elhadd T; Ali H; Baagar K; Abdel Hakam IA; Al-Mohanadi DHS; Naem E; Al Abdulla A; Mohammed K; Abou-Samra AB
Diabetes Metab Syndr; 2018 Nov; 12(6):965-968. PubMed ID: 29895446
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
16. Achieving safer Ramadan fasting by keeping flexible glycemic targets during the day and tighter targets during the night in insulin treated people with type 2 diabetes.
Ahmedani MY; Ghafoor E
Diabetes Res Clin Pract; 2020 Jul; 165():108234. PubMed ID: 32450103
[TBL] [Abstract][Full Text] [Related]
17. Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM).
Lessan N; Hannoun Z; Hasan H; Barakat MT
Diabetes Metab; 2015 Feb; 41(1):28-36. PubMed ID: 25497966
[TBL] [Abstract][Full Text] [Related]
18. Outcome of focused pre-Ramadan education on metabolic and glycaemic parameters in patients with type 2 diabetes mellitus.
El Toony LF; Hamad DA; Omar OM
Diabetes Metab Syndr; 2018 Sep; 12(5):761-767. PubMed ID: 29729978
[TBL] [Abstract][Full Text] [Related]
19. Artificial Intelligence (AI) based machine learning models predict glucose variability and hypoglycaemia risk in patients with type 2 diabetes on a multiple drug regimen who fast during ramadan (The PROFAST - IT Ramadan study).
Elhadd T; Mall R; Bashir M; Palotti J; Fernandez-Luque L; Farooq F; Mohanadi DA; Dabbous Z; Malik RA; Abou-Samra AB;
Diabetes Res Clin Pract; 2020 Nov; 169():108388. PubMed ID: 32858096
[TBL] [Abstract][Full Text] [Related]
20. Fasting in Ramadan is not associated with deterioration of chronic kidney disease: A prospective observational study.
Kara E; Sahin OZ; Kizilkaya B; Ozturk B; Pusuroglu G; Yildirim S; Sevinc M; Sahutoglu T
Saudi J Kidney Dis Transpl; 2017; 28(1):68-75. PubMed ID: 28098105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
